| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| U J Kang, R E Burke, S Fah. Tardive dystonia. Advances in neurology. vol 50. 1988-09-01. PMID:3400500. |
patients developed tardive dystonia even after relatively short duration of exposure to dopamine antagonists (21% within 1 year). |
1988-09-01 |
2023-08-11 |
Not clear |
| A E Lan. Dopamine agonists in the treatment of dystonia. Clinical neuropharmacology. vol 8. issue 1. 1985-05-14. PMID:3884150. |
dopamine agonists in the treatment of dystonia. |
1985-05-14 |
2023-08-11 |
Not clear |
| R E Burke, A Reches, M M Traub, J Ilson, M Swash, S Fah. Tetrabenazine induces acute dystonic reactions. Annals of neurology. vol 17. issue 2. 1985-04-10. PMID:3977303. |
because dystonic reactions have previously been reported only after dopamine receptor blockade and not with dopamine depletion, it is likely that the ability of tetrabenazine to induce acute dystonia is due to its dopamine receptor blocking properties. |
1985-04-10 |
2023-08-11 |
Not clear |
| R E Burke, A Reches, M M Traub, J Ilson, M Swash, S Fah. Tetrabenazine induces acute dystonic reactions. Annals of neurology. vol 17. issue 2. 1985-04-10. PMID:3977303. |
because tetrabenazine can induce acute dystonia even when combined with alpha-methyl-p-tyrosine, presynaptic dopamine stores may not be necessary for these reactions to occur. |
1985-04-10 |
2023-08-11 |
Not clear |
| C N Karson, R S Burns, P A LeWitt, N L Foster, R P Newma. Blink rates and disorders of movement. Neurology. vol 34. issue 5. 1984-05-23. PMID:6231489. |
blink rate, a putative noninvasive marker of central dopamine activity, was assessed in medication-free patients with parkinson's disease, progressive supranuclear palsy, huntington's disease, and dystonia. |
1984-05-23 |
2023-08-12 |
Not clear |
| S M Stahl, J A Yesavage, P A Berge. Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia. The Journal of clinical psychiatry. vol 43. issue 11. 1983-02-14. PMID:7174619. |
since tardive dyskinesia is hypothesized to be characterized by dopamine excess and acetylcholine deficiency, a physostigmine infusion may help differentiate these two disorders by exacerbating meige dystonia but improving tardive dyskinesia. |
1983-02-14 |
2023-08-12 |
Not clear |
| S M Stahl, P A Berge. Bromocriptine, physostigmine, and neurotransmitter mechanisms in the dystonias. Neurology. vol 32. issue 8. 1982-09-10. PMID:6124899. |
we studied eight patients with different types of dystonia by administering agonists and antagonists of acetylcholine (ach) and dopamine (da). |
1982-09-10 |
2023-08-12 |
Not clear |
| D E Casey, J Gerlach, E Christensso. Dopamine, acetylcholine, and GABA effects in acute dystonia in primates. Psychopharmacology. vol 70. issue 1. 1980-12-18. PMID:6775341. |
dopamine, acetylcholine, and gaba effects in acute dystonia in primates. |
1980-12-18 |
2023-08-12 |
monkey |
| J J Askenasy, T J Oberman, M Herzberg, R Carasso, M Streifle. Serum dopamine beta hydroxylase activity and metoclopramide provocative test in torsion dystonia. Journal of neural transmission. vol 47. issue 1. 1980-05-23. PMID:7359123. |
serum dopamine beta hydroxylase activity and metoclopramide provocative test in torsion dystonia. |
1980-05-23 |
2023-08-12 |
Not clear |
| E S Tolosa, C La. Meige disease: striatal dopaminergic preponderance. Neurology. vol 29. issue 8. 1979-09-27. PMID:379689. |
a dopamine agonist (apomorphine) and a cholinomimetic drug (physostigmine) were administered to five patients with blepharospasm and oromandibular dystonia (meige disease). |
1979-09-27 |
2023-08-11 |
Not clear |
| C J Crosley, P T Swende. Dystonia associated with carbamazepine administration: experience in brain-damaged children. Pediatrics. vol 63. issue 4. 1979-07-28. PMID:440873. |
the currently available clinical and neuropharmacologic data suggest that carbamazepine may be an antagonist of dopamine and that this property is responsible for the production of dystonia. |
1979-07-28 |
2023-08-11 |
Not clear |
| K Tabaddor, L I Wolfson, N S Sharples. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia. Neurology. vol 28. issue 12. 1979-03-24. PMID:569784. |
diminished ventricular fluid dopamine metabolites in adult-onset dystonia. |
1979-03-24 |
2023-08-11 |
Not clear |
| K Tabaddor, L I Wolfson, N S Sharples. Diminished ventricular fluid dopamine metabolites in adult-onset dystonia. Neurology. vol 28. issue 12. 1979-03-24. PMID:569784. |
homovanillic acid (hva) and 5-hydroxyindoleacetic acid (5-hiaa), the respective metabolites of dopamine and serotonin, were measured in ventricular fluid obtained from 20 patients with torsion dystonia at the time of ventriculography prior to thalamic surgery. |
1979-03-24 |
2023-08-11 |
Not clear |
| N Inoue, Y Tsukada, A Barbea. Behavioral effects in rats following intrastriatal microinjection of manganese. Brain research. vol 95. issue 1. 1975-11-20. PMID:1171715. |
repeated or chronic administration of this metal in man or animals is known to result in a brain dopamine and/or serotonin deficit commensurate with the clinical manifestations of bradykinesia and dystonia. |
1975-11-20 |
2023-08-11 |
rat |